These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 6665707)
21. A clinical trial of timolol and epinephrine in the treatment of primary open-angle glaucoma. Alexander DW; Berson FG; Epstein DL Ophthalmology; 1988 Feb; 95(2):247-51. PubMed ID: 3050678 [TBL] [Abstract][Full Text] [Related]
22. Therapeutic response interactions between timolol maleate and dipivefrin hydrochloride. West RH; Gillies WE; Brooks AM Aust N Z J Ophthalmol; 1987 May; 15(2):131-4. PubMed ID: 3620185 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of multiple doses of 4 and 6% timolol, and timolol combined with 2% pilocarpine in clinically normal beagles and beagles with glaucoma. Gelatt KN; Larocca RD; Gelatt JK; Strubbe DT; MacKay EO Am J Vet Res; 1995 Oct; 56(10):1325-31. PubMed ID: 8928950 [TBL] [Abstract][Full Text] [Related]
25. The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group. Diestelhorst M Graefes Arch Clin Exp Ophthalmol; 2000 May; 238(5):433-9. PubMed ID: 10901475 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of timolol maleate combination therapy in chronic open-angle glaucoma. Keates EU Am J Ophthalmol; 1979 Sep; 88(3 Pt 2):565-71. PubMed ID: 484687 [TBL] [Abstract][Full Text] [Related]
27. Additive effect of betaxolol and epinephrine in primary open angle glaucoma. Allen RC; Epstein DL Arch Ophthalmol; 1986 Aug; 104(8):1178-84. PubMed ID: 2874783 [TBL] [Abstract][Full Text] [Related]
28. The additional pressure-lowering effect in patients with glaucoma of pilocarpine 2 per cent, adrenaline 1 per cent, or guanethidine 3 per cent with adrenaline 0.5 per cent and timolol 0.25 per cent: a double-blind cross-over study. O'Connor MA; Mooney DJ Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 6)():588-92. PubMed ID: 6385355 [TBL] [Abstract][Full Text] [Related]
29. Restoring sensitivity to timolol after long-term drift in primary open-angle glaucoma. Gandolfi SA Invest Ophthalmol Vis Sci; 1990 Feb; 31(2):354-8. PubMed ID: 2406218 [TBL] [Abstract][Full Text] [Related]
30. Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma. Agarwal HC; Gupta V; Sihota R J Ocul Pharmacol Ther; 2003 Apr; 19(2):105-12. PubMed ID: 12804055 [TBL] [Abstract][Full Text] [Related]
31. [Efficacy and safety of long-term maintenance treatment with timolol ophthalmic solution in chronic open-angle glaucoma (author's transl)]. Katz IM Klin Monbl Augenheilkd; 1979 Aug; 175(2):225-31. PubMed ID: 392172 [TBL] [Abstract][Full Text] [Related]
32. Experience with dipivalyl epinephrine. Its effectiveness, alone or in combination, and its side effects. Cebon L; West RH; Gillies WE Aust J Ophthalmol; 1983 Aug; 11(3):159-61. PubMed ID: 6639507 [TBL] [Abstract][Full Text] [Related]
33. [The effect of timolol/pilocarpine combinations with a fixed ratio compared with 0.5% timolol in the treatment of open-angle glaucoma]. Puustjärvi T; Aine E; Hakala T Fortschr Ophthalmol; 1988; 85(1):76-8. PubMed ID: 3371819 [No Abstract] [Full Text] [Related]
34. Prepared association of metipranolol 0.1% + pilocarpine 2% and of timolol 0.5% + pilocarpine 2%. Comparison of clinical efficacy and topical tolerability in the treatment of patients affected by POAG tonometrically uncontrolled with beta-blocker alone (two-centre study). Boles Carenini B; Brogliatti B; Dorigo MT; Vadalà G; Protti R; Bellone A Acta Ophthalmol Scand Suppl; 1997; (224):54-5. PubMed ID: 9589740 [No Abstract] [Full Text] [Related]
35. Timolol versus pilocarpine separately or combined with acetazolamide-effects on intraocular pressure. Calissendorff B; Marén N; Wettrell K; Ostberg A Acta Ophthalmol (Copenh); 1980 Aug; 58(4):624-31. PubMed ID: 7010886 [TBL] [Abstract][Full Text] [Related]
36. Interaction of dipivefrin and epinephrine with the pilocarpine ocular therapeutic system (Ocusert). Duffey RJ; Ferguson JG Arch Ophthalmol; 1986 Aug; 104(8):1135-6. PubMed ID: 3741240 [No Abstract] [Full Text] [Related]
37. The effect of timolol-dorzolamide and timolol-pilocarpine combinations on ocular blood flow in patients with glaucoma. Uva MG; Longo A; Reibaldi M; Reibaldi A Am J Ophthalmol; 2006 Jun; 141(6):1158-60. PubMed ID: 16765700 [TBL] [Abstract][Full Text] [Related]
38. Oral and topical adrenergic beta-receptor blockers in glaucoma treatment. A multicenter study. Ohrström A; Kättström O; Polland W; Mortensen J; Stenström B Acta Ophthalmol (Copenh); 1984 Oct; 62(5):681-95. PubMed ID: 6391072 [TBL] [Abstract][Full Text] [Related]
39. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group. Strahlman ER; Vogel R; Tipping R; Clineschmidt CM Ophthalmology; 1996 Aug; 103(8):1283-93. PubMed ID: 8764800 [TBL] [Abstract][Full Text] [Related]
40. Timolol-pilocarpine fixed-ratio combinations in the treatment of chronic open angle glaucoma. Moriarty AP; Dowd TC Arch Ophthalmol; 1993 Oct; 111(10):1313-4. PubMed ID: 8216000 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]